Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018)
Pharma-Bio Serv's (PBSV) quarterly Cash from Discontinued Operations came in at 325159.0 in Q4 2018, down 41.85% on a QoQ basis from 559219.0 in Q3 2018.
Pharma-Bio Serv (PBSV) Cash from Discontinued Operations (2018) Analysis & Trends
Pharma-Bio Serv (PBSV) has 1 years of Cash from Discontinued Operations data on file, last reported at 325159.0 in Q4 2018.
- Quarterly Cash from Discontinued Operations changed N/A year-over-year to 325159.0 in Q4 2018, while the trailing twelve-month figure through Jul 2019 was 325159.0 (changed N/A YoY) and the FY2018 annual result came in at 728726.0, up 192.75% from the prior year.
- Cash from Discontinued Operations declined to 325159.0 in Q4 2018, from 559219.0 in the prior quarter.
- In the past five years, Cash from Discontinued Operations ranged from a high of 559219.0 in Q3 2018 to a low of 277995.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Discontinued Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Pharma-Bio Serv | 12.37 Mn | 3.89 Mn | 902,041.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2018 | 325,159.00 |
| Oct 31, 2018 | 325,159.00 |
| Jul 31, 2018 | 559,219.00 |
| Jul 31, 2018 | 559,219.00 |
| Apr 30, 2018 | -277,995.00 |
| Apr 30, 2018 | -277,995.00 |
| Jan 31, 2018 | 122,343.00 |
| Jan 31, 2018 | 122,343.00 |